Pages that link to "Q72643302"

The following pages link to Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: Direct evidence for enhanced platelet reactivity in vivo (Q72643302):

Displaying 42 items.

• Loss of high-affinity prostacyclin receptors in platelets and the lack of prostaglandin-induced inhibition of platelet-stimulated thrombin generation in subjects with spinal cord injury (Q33613498) (← links)
• Antiplatelet therapies: from aspirin to GPIIb/IIIa-receptor antagonists and beyond (Q33771811) (← links)
• Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction (Q34117248) (← links)
• Protein kinase C ε expression in platelets from patients with acute myocardial infarction (Q34447109) (← links)
• Study on the platelet factor and beta-thromboglobulin in the patients with ischemic heart disease (Q38638225) (← links)
• Prostaglandins and the cardiovascular system: a review and update (Q36682178) (← links)
• Non-conventional hemostatic risk factors for coronary heart disease in individuals with spinal cord injury (Q37878848) (← links)
• Plasma levels of platelet secretory proteins (Q38165845) (← links)
• Chemistry, Measurement, and Clinical Significance of Platelet Specific Proteins (Q40105524) (← links)
• Are platelet factor 4 and β-thromboglobulin markers of cardiovascular disorders? (Q40110160) (← links)
• Coagulopathy and platelet activation in Kawasaki syndrome: Identification of patients at high risk for development of coronary artery aneurysms (Q40825705) (← links)
• Laboratory diagnosis of hemorrhagic and thrombotic disorders. (Q41024567) (← links)
• Platelet activation during myocardial ischaemia: a contributory arrhythmogenic mechanism (Q41290150) (← links)
• Histamine-induced spasm not significantly modulated by prostanoids in a swine model of coronary artery spasm (Q42225291) (← links)
• Aspirin for unstable angina? (Q43173766) (← links)
• Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease (Q43261650) (← links)
• Inhibition of Platelet-Mediated Clot Retraction by Integrin Antagonists (Q47820591) (← links)
• Oral Antiplatelet Efficacy of the Platelet GPIIb/IIIa Antagonist, DMP754 in Non-Human Primates (Q47913511) (← links)
• Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease (Q50938987) (← links)
• Intranasal Absorption of the Platelet Glycoprotein IIb/IIIa Receptor Antagonist, DMP 755, and the Effect of Anesthesia on Nasal Bioavailability (Q51532205) (← links)
• Perioperative myocardial ischemia: Early diagnosis using the pulmonary artery catheter (Q51702381) (← links)
• Changes in hemostatic function at times of cyclic variation in occupational stress (Q52005397) (← links)
• Conversion from chronic to acute coronary artery disease: Speculation regarding mechanisms (Q57636187) (← links)
• Plasma levels of platelet-derived growth factor in normal subjects and patients with ischemic heart disease (Q67903644) (← links)
• Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin (Q68416136) (← links)
• Vasoconstrictor activity of coronary sinus plasma from patients with coronary artery disease (Q69026924) (← links)
• Effect of pacing-induced myocardial ischemia on platelet activation and fibrin formation in the coronary circulation (Q70032460) (← links)
• Pathophysiology of unstable angina (Q70150299) (← links)
• Effects of provocation on transcardiac thromboxane in patients with coronary artery disease (Q71674905) (← links)
• Platelet factor 4 release during exercise in patients with coronary artery disease (Q72585497) (← links)
• Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction (Q72721569) (← links)
• Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders (Q72786517) (← links)
• Lack of elevation of platelet factor IV in plasma from patients with myocardial infarction (Q72825502) (← links)
• Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists (Q73676390) (← links)
• Differential Effects of Anticoagulants on the Activation of Platelets Ex Vivo (Q73914766) (← links)
• Effects of ionic and non-ionic contrast media on platelet function as evaluated by plasma concentration of beta-thromboglobulin (Q74321220) (← links)
• Intravenous and Oral Antiplatelet/Antithrombotic Efficacy and Specificity of XR300, a Novel Nonpeptide Platelet GPIIb/IIIa Antagonist (Q74350744) (← links)
• Pharmacodynamics and pharmacokinetics of DMP 728, a platelet GPIIb/IIIa antagonist, in healthy subjects (Q74444621) (← links)
• Intranasal antiplatelet/antithrombotic efficacy of a novel platelet GPIIB/IIIA receptor antagonist DMP755 (Q77525370) (← links)
• Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression (Q77856496) (← links)
• Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications (Q78035738) (← links)
• The utility of inflammation and platelet biomarkers in patients with acute coronary syndromes (Q90039555) (← links)